Implantable Sensor Device Claims to Offer Continuous Cancer Monitoring

摘要

Researchers at MIT are claiming an in vivo sensor device that could be implanted during a cancer tissue biopsy and remain in patients for continuous monitoring of the disease's impact on their health.rnThe medical device aims to offer a more accurate tracking of cancer and how a patient is responding to treatment with the ability to repeatedly sample the local environment for tumor biomarker, chemotherapeutic agent, and tumor metabolite concentrations, which could improve early detection of metastasis and personalized therapy.